Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeutics

Tetsuro Yoshimaru(National Institute of Biomedical Innovation, Health and Nutrition), Toyomasa Katagiri(National Institute of Biomedical Innovation, Health and Nutrition)
Scientific Reports
May 8, 2017
10.1038/s41598-017-01951-6
Cited by 13

Related Papers

Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases
|Nature Genetics|2020|591
Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs
|Oncogene|2003|323
Mutation analysis in the BRCA2 gene in primary breast cancers
|Nature Genetics|1996|279
PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase, a Putative Cancer/Testis Antigen with an Oncogenic Activity in Breast Cancer
|Cancer Research|2006|180
Critical Roles of Mucin 1 Glycosylation by Transactivated Polypeptide <i>N</i> -Acetylgalactosaminyltransferase 6 in Mammary Carcinogenesis
|Cancer Research|2010|178